Latest Share Chat

Limitless Earth Invests USD500,000 In US-Based Chronix Biomedical

Thu, 08th Oct 2015 07:19

LONDON (Alliance News) - Investment company Limitless Earth PLC on Thursday said it has invested USD500,000 in US-based Chronix Biomedical Inc through convertible preference stock.

Chronix Biomedical is a San Jose, California-based molecular diagnostics company which is developing blood tests to be used for cancer detection and organ transplantation.

Limitless Earth has invested USD500,000 to take a stake of around 0.7% in the company. The investment values Chronix at around USD69 million.

Shares in Limitless Earth were untraded on Thursday morning, having last traded at 4.80 pence.

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Related Shares

More News

6 Dec 2023 15:13

UK shareholder meetings calendar - next 7 days

30 Oct 2023 20:08

IN BRIEF: Limitless Earth half-year loss stretches

Limitless Earth PLC - makes investments in firms that show potential to generate returns through capital appreciation - Pretax loss in six months to J...

28 Jul 2023 20:46

TRADING UPDATES: Limitless Earth loss widens; Black Sea NAV rises

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

20 Sep 2019 14:06

Limitless Earth Invests Further USD100,000 In Chronix Biomedical

(Alliance News) - Limitless Earth PLC on Friday said it has made a further investment in Chronix Biomedical, Inc, a developer of novel blood-based can...

20 Sep 2019 11:02

Limitless Earth puts another $0.1m into Chronix Biomedical

(Sharecast News) - Investment company Limitless Earth has made a further investment in Chronix Biomedical, a developer of novel blood-based cancer mol...